MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
1049.59%
Quick Ratio
1049.59%
Cash Ratio
1022.57%
Debt to Asset Ratio
10.31%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Prepaid expenses and other curre...
    • Operating lease right of use ass...
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Operating lease liabilities
    • Others

Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
56,129 40,265 48,616 31,194
Collaboration receivable, current - related party
0 25,359 868 24,453
Other receivables
44 28 1,591 2,460
Prepaid expenses and other current assets
1,439 1,634 1,248 1,295
Total current assets
57,612 67,286 52,323 59,402
Operating lease right of use assets
1,256 1,480 1,694 2,564
Other assets
153 153 153 153
Total assets
59,021 68,919 54,170 62,119
Deferred revenue, current
NaN 0 0 0
Accounts payable
217 693 1,395 780
Accrued expenses and other current liabilities
3,142 5,578 7,809 6,727
Operating lease liabilities
1,967 1,956 1,899 1,844
Income taxes payable
163 383 163 163
Deferred revenue, current - related party
0 258 2,383 5,431
Total current liabilities
5,489 8,868 13,649 14,945
Non-current operating lease liabilities
507 939 1,452 1,771
Deferred revenue, non-current
NaN 0 12,575 12,575
Deferred revenue, non-current - related party
NaN 0 0 0
Other long-term liabilities
91 91 NaN NaN
Total liabilities
6,087 9,898 27,676 29,291
Common stock, 0.001 par value 120,000,000 shares authorized as of march 31, 2026 and december 31, 2025 57,891,493 shares issued and outstanding as of march 31, 2026 and 56,414,657 shares issued and outstanding as of december 31, 2025
58 56 56 56
Additional paid-in capital
511,145 510,031 509,024 507,976
Accumulated deficit
-458,269 -451,066 -482,586 -475,204
Total stockholders' equity
52,934 59,021 26,494 32,828
Total liabilities and stockholders' equity
59,021 68,919 54,170 62,119
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$56,129K Prepaid expenses andother current assets$1,439K Other receivables$44K Total current assets$57,612K Operating lease right ofuse assets$1,256K Other assets$153K Total assets$59,021K Total liabilities andstockholders' equity$59,021K Total stockholders'equity$52,934K Total liabilities$6,087K Accumulated deficit-$458,269K Additional paid-in capital$511,145K Total currentliabilities$5,489K Non-current operating leaseliabilities$507K Other long-termliabilities$91K Common stock, 0.001 parvalue 120,000,000...$58K Accrued expenses andother current...$3,142K Operating leaseliabilities$1,967K Accounts payable$217K Income taxes payable$163K

Spero Therapeutics, Inc. (SPRO)

Spero Therapeutics, Inc. (SPRO)